TMC
OPXAW

Trellus Management Company’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Trellus Management Company’s Portfolio OPXAW Stock Details OPXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,600
Closed -$2K – 116
2015
Q2 		$2K Buy
+12,600
New +$1.89K ﹤0.01% 97

Other funds holding OPXAW

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Trellus Management Company's OPXAW Position: Q3 2015 in Review

Trellus Management Company sold out of Opexa Therapeutics, Inc. (OPXAW) in Q3 2015, closing a stake of 12,600 shares — an estimated $2K sold.

Trellus Management Company first reported a position in OPXAW in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 5 funds tracked by Wall St. Rank hold OPXAW as of Q3 2015.

  • Trellus Management Company reported no remaining Opexa Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Trellus Management Company sold 12,600 Opexa Therapeutics, Inc. shares in Q3 2015, an estimated $2K.
  • Trellus Management Company first reported a position in Opexa Therapeutics, Inc. in Q2 2015 and held it in 1 quarter.
  • Trellus Management Company's Opexa Therapeutics, Inc. position peaked at $2K in Q2 2015.
  • 5 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q3 2015.

Based on Trellus Management Company's 13F filing for Q3 2015, filed 14 Oct 2015.